|
Related Party Transactions
|
12 Months Ended |
|---|---|
|
Dec. 31, 2014
|
|
| Related Party Transactions [Abstract] | |
| Related Party Transactions |
5. Related Party Transactions At December 31, 2014 and 2013 deferred payments totaling $25,500 and $25,500, respectively, were owed to former directors in connection with their service on our Board and are included in the accompanying balance sheets in accounts payable and accrued expenses. As of December 31, 2014, Intrexon Corporation owned approximately 24.4% of our outstanding common stock. During the year ended December 31, 2014 and 2013, we paid $866,030 and $1,463,019, respectively to Intrexon Corporation (“Intrexon”) under the Exclusive Channel Collaboration Agreement to develop and commercialize lantibiotics (the “Lantibiotic ECC”) and we paid $46,892 and $0, respectively to Intrexon under the Exclusive Channel Collaboration Agreement to develop and commercialize genetically modified probiotics (the “LBPs ECC”). |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|